October 28, 2019 PAP-Q3-19-CL-004
Company Profile | BioVectra
BioVectra has two locations in this region, one in Charlottetown, Prince Edward Island, and one in Windsor, Nova Scotia. They are a full-service contract development and manufacturing organization (CDMO) that specializes in microbial fermentation, complex chemistry, high potency APIs, biologics, process and analytical development and drug development, serving pharmaceutical and biotech companies with cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs).
These photographs depict some of the natural beauty and idyllic charm of Prince Edward Island and illustrate what makes Prince Edward Island such a wonderful place to both live and work.
takes over the island as cyclists enjoy the ride through an iconic landscape.
You can’t miss fresh seafood and a cold beer at Richard’s, a beloved local eatery.
Prince Edward Island is famous for its access to miles of beach.
Enjoy fresh air and greenery as far as the eye can see.
Picturesque sunsets set the scene nightly.
To learn more about BioVectra and our current opportunities, or start your journey, visit www.biovectra.com/careers.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
BioVectra is a CDMO that serves pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients. An innovative and reliable service partner with a strong regulatory history, BioVectra has over 45 years of experience specializing in cGMP microbial fermentation, complex chemistry/high-potency APIs, biologics, and formulation development.